The weekly litigation news digest is live. Subscribe now

IP Verse

Modified Nucleotides For Polynucleotide Sequencing - EP3363809

The patent EP3363809 was granted to Illumina Cambridge on Apr 8, 2020. The application was filed on Aug 22, 2003 under application number EP18157128A. The patent is currently recorded with a legal status of "Revoked".

EP3363809

ILLUMINA CAMBRIDGE
Application Number
EP18157128A
Filing Date
Aug 22, 2003
Status
Revoked
Feb 2, 2024
Publication Date
Apr 8, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
LATVIA MGI TECH SIAAug 24, 2020HOFFMANN EITLEADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS5302509
DESCRIPTIONWO0006770
DESCRIPTIONWO0229003
DESCRIPTIONWO03048387
OPPOSITIONEP2119722
OPPOSITIONGB230037
OPPOSITIONGB303924
OPPOSITIONUS2003104437
OPPOSITIONUS227131
OPPOSITIONWO0050642
OPPOSITIONWO0229003
OPPOSITIONWO2004018497
OPPOSITIONWO2005024010
OPPOSITIONWO9106678
SEARCHWO0229003

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents